Advertisement
Screener

CEPHALON INC Patents: Expired

CEPHALON INC Expired Patents

8 granted patents the USPTO lists as expired; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2019-07-31: Application 16527354; Invention ANTI-CXCR2 ANTIBODIES AND USES THEREOF; Applicant Cephalon, Inc.; Status Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362.
  • 2017-05-25: Application 15529883; Invention CRYSTALLINE FORMS OF PARP INHIBITORS; Applicant CEPHALON, INC.; Status Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362.
  • 2016-05-04: Application 15146164; Invention FUSED BICYCLIC 2,4-DIAMINOPYRIMIDINE DERIVATIVE AS A DUAL ALK AND FAK INHIBITOR; Applicant Cephalon, Inc.; Status Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362.
  • 2015-11-18: Application 14944668; Invention PYRROLOTRIAZINES AS ALK INHIBITORS; Applicant Cephalon, Inc.; Status Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2019-07-3116527354ANTI-CXCR2 ANTIBODIES AND USES THEREOFCephalon, Inc.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622022-05-1711332534US20200040089A1
Doris Shim Siew Chen
Lynn Dorothy Poulton
Adam Clarke
David Jose Simon Laine
Matthew Pollard
Bridget Ann Cooksey
Anthony Doyle
Jason William Gill
Australia
Australia
Australia
Australia
Australia
Australia
Australia
Australia
DEBERRY, REGINA M
2017-05-2515529883CRYSTALLINE FORMS OF PARP INHIBITORSCEPHALON, INC.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622018-12-1110150772US20170267683A1
Stephen J. BIERLMAIER
Ralph C. HALTIWANGER
Martin J. JACOBS
United States
United States
United States
HEYER, DENNIS
2016-05-0415146164FUSED BICYCLIC 2,4-DIAMINOPYRIMIDINE DERIVATIVE AS A DUAL ALK AND FAK INHIBITORCephalon, Inc.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622017-04-189623026US20160243119A1
Shawn P. Allwein
Laurent Courvoisier (deceased)
Martin J. Jacobs
Gregory R. Ott
United States
United States
United States
United States
PAGANO, ALEXANDER R
2015-11-1814944668PYRROLOTRIAZINES AS ALK INHIBITORSCephalon, Inc.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622016-09-139440984US20160068535A1
Ralph C. Haltiwanger
Eugen F. Mesaros
Gregory R. Ott
United States
United States
United States
DAVIS, BRIAN J
2014-07-3014446411Imidazo[4,5-b]pyridine Derivatives as ALK and JAK Modulators for the Treatment of Proliferative DisordersCephalon, Inc.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622016-01-199238656US20140350011A1
Henry J. Breslin
Matthew A. Curry
Diane E. Gingrich
Keith S. Learn
Gregory R. Ott
Jason C. Wagner
United States
United States
United States
United States
United States
United States
AGUIRRE, AMANDA L
2013-09-1314025986Macrocyclic Compounds as ALK, FAK and JAK2 InhibitorsCephalon, Inc.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622016-11-089487529US20140031351A1
Henry J. Breslin
Bruce D. Dorsey
Gregory R. Ott
United States
United States
United States
JEAN-LOUIS, SAMIRA JM
2013-08-2613975483Substituted Aromatic Sulfur Compounds and Methods of Their UseCephalon, Inc.
University of Utah Research Foundation
University of Hawaii
Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622016-10-259475766US20140005175A1
Bruce D. Dorsey
Scott K. Kuwada
Jay P. Theroff
Craig A. Zificsak
United States
United States
United States
United States
SCHMITT, MICHAEL J
2012-12-0613706835Modafinil CompositionsCEPHALON, INC.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622014-08-198809586US20130096345A1
Magali Bourghol Hickey
Matthew Peterson
Orn Almarsson
Mark Oliveira
United States
United States
United States
United States
KUMAR, SHAILENDRA